THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

The Hydration Pharmaceuticals Company Limited

HPC

AU0000187957

Pharmaceuticals

Delayed Australian S.E. Other stock markets 01:59:56 2024-06-25 EDT			5-day change	1st Jan Change
0.009 ^AUD	-10.00%		-30.77%	-62.50%

05-24	The Hydration Pharmaceuticals Postpones Managing Director Appointment	MT
05-24	The Hydration Pharmaceuticals Company Limited Announces Board Change, Effective 25 May 2024	CI

The Hydration Pharmaceuticals Company Limited Announces Unaudited Sales Results for the Month of January 2023

February 12, 2023 at 04:51 pm

The Hydration Pharmaceuticals Company Limited announced unaudited sales results for the month of January 2023. For the month, the company has achieved its highest ever monthly sales result, generating unaudited net monthly sales of $1.0 million, a 70% rise on the previous corresponding period net sales of $585,000 for January 2022.

Latest news about The Hydration Pharmaceuticals Company Limited

The Hydration Pharmaceuticals Postpones Managing Director Appointment	05-24	MT
The Hydration Pharmaceuticals Company Limited Announces Board Change, Effective 25 May 2024	05-23	CI
The Hydration Pharmaceuticals Issues Shares as Interest Prepayment	05-10	MT
The Hydration Pharmaceuticals' Revenue Falls 14% in March Quarter	04-30	MT
The Hydration Pharmaceuticals Co. Secures AU$1.7 Million in Funding from Variation of Facility Agreement	03-27	MT
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
10,387,823 Options of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 14-DEC-2023.	12-13	CI
17,482,735 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 14-DEC-2023.	12-13	CI
6,671,720 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-DEC-2023.	12-09	CI
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
The Hydration Pharmaceuticals Company Limited Announces Resignation of Gretta van Riel as Non-Executive Director, Effective September 26, 2023	23-08-27	CI
The Hydration Pharmaceuticals Posts 24% Jump in Q2 Net Sales	23-07-19	MT
The Hydration Pharmaceuticals Achieves Daily Retail Sales Milestone on Amazon Canada	23-06-30	MT
9,568,677 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-JUN-2023.	23-06-09	CI
The Hydration Pharmaceuticals Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
The Hydration Pharmaceuticals Sees Record High Sales of $1 Million in January	23-02-13	MT
The Hydration Pharmaceuticals Company Limited Announces Unaudited Sales Results for the Month of January 2023	23-02-12	CI
The Hydration Pharmaceuticals Company Limited Announces Executive Changes	23-02-08	CI
The Hydration Pharmaceuticals Posts 92% Jump in Annual Retail Sales Through Amazon USA	22-12-22	MT
10,835,361 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 10-DEC-2022.	22-12-09	CI
2,416,700 Ordinary Shares of The Hydration Pharmaceuticals Company Limited are subject to a Lock-Up Agreement Ending on 3-DEC-2022.	22-12-02	CI
The Hydration Pharmaceuticals Launches Co-Branded Product; Shares Slip 4%	22-12-01	MT
The Hydration Pharmaceuticals Company Limited Launches Co-Branded Product	22-12-01	CI
Shay Mitchell Debuts New Lemon Squeeze Flavor Rapid Hydration Drink in Collaboration with HydraLyte	22-12-01	CI
Hydration Pharmaceuticals Company Limited Secures Key Regulatory Approval for Product Manufacturing for the Canadian Market	22-11-14	CI

Chart The Hydration Pharmaceuticals Company Limited

Duration

Period

Chart The Hydration Pharmaceuticals Company Limited

More charts

Company Profile

The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.

Sector

Pharmaceuticals

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED	-62.50%	1.82M
ELI LILLY AND COMPANY	+55.19%	815B
NOVO NORDISK A/S	+47.26%	654B
JOHNSON & JOHNSON	-6.09%	354B
MERCK & CO., INC.	+21.92%	337B
ASTRAZENECA PLC	+18.40%	247B
ROCHE HOLDING AG	+3.64%	229B
NOVARTIS AG	+12.98%	219B
AMGEN INC.	+10.86%	171B
PFIZER, INC.	-2.78%	159B